Your payment is in progress...

Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Research Report 2022

Published on: Jul 2022 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 90

Market Analysis and Insights: Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market.
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Scope and Market Size
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Paracetamol
Ibuprofen
Aspirin
Naproxen
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Dr. Reddy's Laboratories
Actavis
Wuxi Apptec
Zhejiang NHU

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Paracetamol
1.2.3 Ibuprofen
1.2.4 Aspirin
1.2.5 Naproxen
1.2.6 Others
1.3 Market by Application
1.3.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2017-2028)
2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Region
2.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Region (2017-2022)
2.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2023-2028)
2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Dynamics
2.3.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Trends
2.3.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
2.3.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
2.3.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue
3.1.1 Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2017-2022)
3.1.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2017-2022)
3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
3.4 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio
3.4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2021
3.5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served
3.6 Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
3.7 Date of Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Type
4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2017-2022)
4.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2023-2028)
5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Application
5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Application (2017-2022)
5.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2028)
6.2 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)
6.3 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2028)
7.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)
7.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2028)
8.2 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)
8.3 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2028)
9.2 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)
9.3 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2028)
10.2 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)
10.3 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.1.4 Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.2.4 Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.2.5 Pfizer Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.3.4 Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Detail
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.4.4 Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Hospira
11.5.1 Hospira Company Detail
11.5.2 Hospira Business Overview
11.5.3 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.5.4 Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.5.5 Hospira Recent Development
11.6 Lonza Group
11.6.1 Lonza Group Company Detail
11.6.2 Lonza Group Business Overview
11.6.3 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.6.4 Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.6.5 Lonza Group Recent Development
11.7 Mylan
11.7.1 Mylan Company Detail
11.7.2 Mylan Business Overview
11.7.3 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.7.4 Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.7.5 Mylan Recent Development
11.8 Aurobindo Pharma
11.8.1 Aurobindo Pharma Company Detail
11.8.2 Aurobindo Pharma Business Overview
11.8.3 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.8.4 Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.8.5 Aurobindo Pharma Recent Development
11.9 Dr. Reddy's Laboratories
11.9.1 Dr. Reddy's Laboratories Company Detail
11.9.2 Dr. Reddy's Laboratories Business Overview
11.9.3 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.9.4 Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.9.5 Dr. Reddy's Laboratories Recent Development
11.10 Actavis
11.10.1 Actavis Company Detail
11.10.2 Actavis Business Overview
11.10.3 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.10.4 Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.10.5 Actavis Recent Development
11.11 Wuxi Apptec
11.11.1 Wuxi Apptec Company Detail
11.11.2 Wuxi Apptec Business Overview
11.11.3 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.11.4 Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.11.5 Wuxi Apptec Recent Development
11.12 Zhejiang NHU
11.12.1 Zhejiang NHU Company Detail
11.12.2 Zhejiang NHU Business Overview
11.12.3 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.12.4 Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.12.5 Zhejiang NHU Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Paracetamol
Table 3. Key Players of Ibuprofen
Table 4. Key Players of Aspirin
Table 5. Key Players of Naproxen
Table 6. Key Players of Others
Table 7. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2017-2022)
Table 11. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2023-2028)
Table 13. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
Table 14. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
Table 15. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
Table 16. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
Table 17. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players (2017-2022)
Table 19. Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) as of 2021)
Table 20. Ranking of Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
Table 24. Date of Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2017-2022)
Table 28. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2023-2028)
Table 30. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2017-2022)
Table 32. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2023-2028)
Table 34. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028) & (US$ Million)
Table 44. Novartis Company Detail
Table 45. Novartis Business Overview
Table 46. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 47. Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 48. Novartis Recent Development
Table 49. Pfizer Company Detail
Table 50. Pfizer Business Overview
Table 51. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 52. Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 53. Pfizer Recent Development
Table 54. Boehringer Ingelheim Company Detail
Table 55. Boehringer Ingelheim Business Overview
Table 56. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 57. Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 58. Boehringer Ingelheim Recent Development
Table 59. Teva Pharmaceutical Company Detail
Table 60. Teva Pharmaceutical Business Overview
Table 61. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 62. Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 63. Teva Pharmaceutical Recent Development
Table 64. Hospira Company Detail
Table 65. Hospira Business Overview
Table 66. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 67. Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 68. Hospira Recent Development
Table 69. Lonza Group Company Detail
Table 70. Lonza Group Business Overview
Table 71. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 72. Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 73. Lonza Group Recent Development
Table 74. Mylan Company Detail
Table 75. Mylan Business Overview
Table 76. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 77. Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 78. Mylan Recent Development
Table 79. Aurobindo Pharma Company Detail
Table 80. Aurobindo Pharma Business Overview
Table 81. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 82. Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 83. Aurobindo Pharma Recent Development
Table 84. Dr. Reddy's Laboratories Company Detail
Table 85. Dr. Reddy's Laboratories Business Overview
Table 86. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 87. Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 88. Dr. Reddy's Laboratories Recent Development
Table 89. Actavis Company Detail
Table 90. Actavis Business Overview
Table 91. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 92. Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 93. Actavis Recent Development
Table 94. Wuxi Apptec Company Detail
Table 95. Wuxi Apptec Business Overview
Table 96. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)Product
Table 97. Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 98. Wuxi Apptec Recent Development
Table 99. Zhejiang NHU Company Detail
Table 100. Zhejiang NHU Business Overview
Table 101. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)Product
Table 102. Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 103. Zhejiang NHU Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2021 VS 2028
Figure 2. Paracetamol Features
Figure 3. Ibuprofen Features
Figure 4. Aspirin Features
Figure 5. Naproxen Features
Figure 6. Others Features
Figure 7. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application in 2021 & 2028
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
Figure 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region: 2021 VS 2028
Figure 15. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2021
Figure 16. Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2021
Figure 18. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2017-2028)
Figure 20. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2017-2028)
Figure 24. Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2017-2028)
Figure 32. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2017-2028)
Figure 40. Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2017-2028)
Figure 44. Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Novartis Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 47. Pfizer Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 48. Boehringer Ingelheim Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 49. Teva Pharmaceutical Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 50. Hospira Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 51. Lonza Group Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 52. Mylan Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 53. Aurobindo Pharma Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 54. Dr. Reddy's Laboratories Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 55. Actavis Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 56. Wuxi Apptec Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 57. Zhejiang NHU Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

FAQs

Market research is a defined process to collect information about customers, competitors, and everything that a business needs to understand to sustain and grow. It offers important analysis to distinguish and examine the market needs, size, and trends. Market research is generally divided into, primary research and/or secondary research.

The process usually includes collection and interpretation of market data by using statistical and analytical techniques to support the decision making process.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Market research reports provide in-depth analysis about the market conditions and requirements for effective decision making.
The report provides a snapshot of the global market size, segmentation data, marketing growth strategies, market share, export and import information, analysis and forecast of market trends, competition, domestic production, best sales prospects, statistical data, tariffs, regulations, distribution and business practices, end-user analysis, contact points and more.

These research reports include information about competitive strategies, solutions, fact-based research, key takeaways, recommendations, market considerations, emerging business models and market opportunities for multiple segments of an industry.

Market research reports assist in solving business problems and making better decisions to improve business as per the prevalent market trends.
When you place an order with MarketInsightsReports, we try our best to deliver the product as soon as possible. The report will be delivered to you either by email or by physical delivery. If it’s delivered by email the order will be dispatched on the same working day or on the next working day of receipt of payment (unless otherwise specified on our website). There may be exceptions to this if you place order on a non-working day specifically because our publisher partners are located all over the globe. In case of physical delivery report will be couriered to you within 3 working days from the date of the receipt of payment and delivery time will differ based on your location

Any person who has the capacity to make decisions for the business must buy the reports. These reports help management in decision making process. Market research helps person to obtain market information from different sources, and in multiple formats. It aims to study supply and demand, analyze data as per geography, age factors, demography, technology, product, psychographic & gender differences, and many other parameters. Access to in-depth market trends helps person to assess the market effectiveness. Some of the multiple techniques used for market research include customer analysis, choice modeling, competition and risk analysis, product research, advertising the research, marketing mix modeling, simulated test marketing, and more.
Market research studies several features of business environment, such as competitors, market structure, government regulations, economic trends, technological advances and financial analysis of companies, industries, and sectors. This helps person in the decision-making process of planning and implementing strategies for their markets.

The generation of research report is concerned by most clients when purchasing it. Following general steps are taken for generating reports.
1. Choose a topic.
2. Make skeleton catalogue.
3. Fill content. As for report content, there are two main information source, Primary and Secondary data collection. Secondary data collectionrefers to information searched from the Internet or data bought from database. Primary data collection refers to information concluded from telephone interview, face-to-face interview, expert’s interview, meeting etc.
4. Audit the report
5. Publish the report.

With regard to information cost, information searching costs the least, database support the second least, and telephone interview the third least. Face-face interview cost higher, in-depth interview much higher and expert interview the highest. A research may adopt all of these approaches, or just some of them.
In general, a good-quality research report needs 1-3 months to be finished. Time and method varies according to different Publishers. Thus, it’s difficult to define an exact procedure or process of making research report. Both time and cost vary. However, specialization has become a basic industry standard. Professional and dedicated products will be more and more popular.
MarketInsightsReports has focused on various fields such as Life Science, IT, Telecommunication, Food& Beverages, Energy & Power, Automotive & Transportation, Materials& Chemicals, Financial Services and many more. These market research reports are available for all regions around the globe.
When you place an order with MarketInsightsReports, we try our best to deliver the product as soon as possible. The report will be delivered to you either by email or by physical delivery. If it’s delivered by email the order will be dispatched on the same working day or on the next working day of receipt of payment (unless otherwise specified on our website).

There may be exceptions to this if you place order on a non-working day specifically because our publisher partners are located all over the globe. In case of physical delivery report will be couriered to you within 3 working days from the date of the receipt of payment and delivery time will differ based on your location

Please Choose License Type

USD $2900
USD $4350
USD $5800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Recognised publishing sources Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Customer Support Customer Support
    Complete pre and post sales support.
  • Safe & Secure Safe & Secure
    Complete secure payment process.